Journal article
SARS: lessons learned from other coronaviruses
Viral immunology, v 16(4), pp 461-474
2003
PMID: 14733734
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
The identification of a new coronavirus as the etiological agent of severe acute respiratory syndrome (SARS) has evoked much new interest in the molecular biology and pathogenesis of coronaviruses. This review summarizes present knowledge on coronavirus molecular biology and pathogenesis with particular emphasis on mouse hepatitis virus (MHV). MHV, a member of coronavirus group 2, is a natural pathogen of the mouse; MHV infection of the mouse is considered one of the best models for the study of demyelinating disease, such as multiple sclerosis, in humans. As a result of the SARS epidemic, coronaviruses can now be considered as emerging pathogens. Future research on SARS needs to be based on all the knowledge that coronavirologists have generated over more than 30 years of research.
Metrics
Details
- Title
- SARS: lessons learned from other coronaviruses
- Creators
- Sonia Navas-Martin - Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6076, USASusan R Weiss
- Publication Details
- Viral immunology, v 16(4), pp 461-474
- Publisher
- Mary Ann Liebert; United States
- Grant note
- AI 47800 / NIAID NIH HHS RG2585B5 / CSR NIH HHS NS21954 / NINDS NIH HHS AI17418 / NIAID NIH HHS NS30606 / NINDS NIH HHS
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Microbiology and Immunology
- Web of Science ID
- WOS:000187756100003
- Scopus ID
- 2-s2.0-0347992844
- Other Identifier
- 991014878089504721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Immunology
- Virology